Avalon GloboCare Corp.
For the period ended Dec 31, 2025. Filed Mar 30, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 30, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| AVALON GLOBOCARE CORP. | ||
| Dated: March 30, 2026 | By: | /s/ Meng Li |
|---|---|---|
| Name: | Meng Li | |
| Title: | Interim Chief Executive Officer and President (Principal Executive Officer) | |
| Dated: March 30, 2026 | By: | /s/ Luisa Ingargiola |
| Name: | Luisa Ingargiola | |
| Title: | Chief Financial Officer (Principal Financial and Accounting Officer) |
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each individual whose signature appears below constitutes and appoints Meng Li and Luisa Ingargiola, and each of them individually, his or her true and lawful attorney-in-fact, with full power of substitution and re-substitution for him or her and in his or her name, place and stead, in any and all capacities to sign any and all amendments to the Annual Report on Form 10-K and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that said attorney-in-fact or his substitute may lawfully do or cause to be done by virtue thereof.
Pursuant to the requirements of the Securities Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Meng Li | Interim Chief Executive Officer | March 30, 2026 |
| Meng Li | (Principal Executive Officer) | |
| /s/ Luisa Ingargiola | Chief Financial Officer | March 30, 2026 |
| Luisa Ingargiola | (Principal Financial and Accounting Officer) | |
| /s/ Wenzhao Lu | Chairman of the Board of Directors | March 30, 2026 |
| Wenzhao Lu | ||
| /s/ Steven A. Sanders | Director | March 30, 2026 |
| Steven A. Sanders | ||
| /s/ Lourdes Felix | Director | March 30, 2026 |
| Lourdes Felix | ||
| /s/ Michael Mathews | Director | March 30, 2026 |
| Michael Mathews | ||
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2025 and 2024
CONTENTS
| Report of Independent Registered Public Accounting Firm (PCAOB No. 2738) | F-2 |
|---|---|
| Consolidated Financial Statements: | |
| Consolidated Balance Sheets - As of December 31, 2025 and 2024 | F-3 |
| Consolidated Statements of Operations and Comprehensive Loss - For the Years Ended December 31, 2025 and 2024 | F-4 |
| Consolidated Statements of Changes in Equity - For the Years Ended December 31, 2025 and 2024 | F-5 |
| Consolidated Statements of Cash Flows – For the Years Ended December 31, 2025 and 2024 | F-6 |
| Notes to Consolidated Financial Statements | F-7 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.